Omada Health, Inc. (OMDA)
- Sector
- Health Care
- Last price
- $18.30
- As of
Kresmion compiles this page from OMDA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Omada Health, Inc. (OMDA): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
See the full OMDA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for OMDA on one page. Preview it with sample data, then open it live with a free account.
Preview the OMDA dossierActive signals for OMDA
- highCONSENSUS_BUY
5 tracked funds increased OMDA this 2026Q2, institutional consensus
- highCONSENSUS_BUY
4 tracked funds increased OMDA this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +140% to OMDA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +5586% to OMDA (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +4167% to OMDA (2026Q2)
FREE, NO ACCOUNT
Every signal on OMDA, as it fires
You are seeing 5 of 20 signals recorded on OMDA since 2026-05-26.
The five above landed across 2 days. The other 15 were recorded on 4 other days. 11 of the 20 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in OMDA (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 68170A108 · 2026Q2 | $37.8M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 68170A108 · 2026Q2 | $26.4M | 0.01% | , |
| Point72 Asset Management, L.P.CUSIP 68170A108 · 2026Q2 | $13.1M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 68170A108 · 2026Q2 | $11.1M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 68170A108 · 2026Q2 | $4.2M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 68170A108 · 2026Q2 | $2.1M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, OMDA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
OMDA against its peers
OMDA's operating margin of -4.6% ranks in the 33rd percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-02.
| Metric | OMDA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 260M USD | 781M USD | 17 | 25 |
| Gross margin | 65.7% | 68.3% | 47 | 15 |
| Operating margin | -4.6% | 1.4% | 33 | 25 |
| Net margin | -4.9% | -0.0% | 37 | 25 |
| Return on equity | -5.6% | -0.2% | 37 | 25 |
| P / E | n/a | 44.4x | n/a | 10 |
| 1 year | n/a | -6.7% | n/a | 23 |
Peers (25): CNMD, USPH, CERT, PNTG, AMN, TNDM, GDRX, PRCT, ALHC, IRMD, STAA, OMCL, TDOC, NVCR, HSTM, ATEC, CSTL, XRAY, LMAT, BVS, WGS, TALK, INSP, SEM, AHCO. Fiscal periods ending between 2025-12-31 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (OMDA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow OMDA on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to OMDA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.